How to Translate Medical Device Documentation into French for EU MDR Compliance

Emi Lecret • October 14, 2026

1. Ensure compliance with EU and French language requirements

Article 10(11) of Regulation (EU) 2017/745 (EU MDR) requires manufacturers to provide device information in the official EU language(s) determined by the Member State where the device is made available. In France, Article R.5211-3 of the French Public Health Code requires French-language documentation, including labelling, instructions for use (IFUs), implant cards, EU declarations of conformity and field safety notices.

2. Identify all documentation requiring translation

Annex I, Section 23 of the MDR specifies requirements for labels, IFUs, safety information, warnings, contraindications and other information supplied with the device. Annex II, Section 2 requires technical documentation to include labels and IFUs in the languages accepted by the target Member States.

3. Use accurate, consistent medical and technical terminology

Maintain consistency between translated IFUs, labels, warnings and other accompanying information. ISO 20417:2026 establishes general requirements for information supplied by medical device manufacturers, while ISO 15223-1:2021 addresses symbols used in medical device information.

4. Preserve safety-critical information

Translate intended purpose, indications, contraindications, residual risks, warnings, precautions and operating instructions without omissions or changes in meaning. Annex I, Sections 23.1(g) and 23.4 of the MDR establish requirements for communicating this information.

5. Adapt the language to the intended users

Annex I, Section 23.1(a) requires IFUs to be readily understood by their intended users, considering their technical knowledge, experience, education and training. Documentation intended for patients or lay users therefore requires appropriately accessible French.

6. Check symbols, units and graphical information

Annex I, Section 23.1(h) requires applicable harmonised standards or common specifications to be followed for symbols and identification colours. Where neither exists, symbols and colours must be explained in the accompanying documentation. ISO 15223-1:2021 provides a relevant framework for medical device symbols.

7. Verify consistency between software interfaces and documentation

The European Commission’s guidance on Member State language requirements also addresses graphical user interfaces (GUIs), including medical applications. Manufacturers should check applicable national requirements and ensure that translated IFUs accurately reflect the terminology and functions displayed in the device interface.

8. Implement translation quality assurance and version control

Translation workflows should include terminology management, bilingual review, verification of numerical values and safety statements, and checks against the final layout. Article 16(3) of the MDR explicitly requires distributors and importers performing translation activities under Article 16(2) to maintain a quality management system ensuring translations are accurate and up to date.

9. Maintain translated documentation throughout the device lifecycle

Ensure that relevant changes to warnings, operating instructions and other safety-related information are reflected in the French documentation. For electronic IFUs, Commission Implementing Regulation (EU) 2021/2226, as amended, establishes specific requirements concerning language availability, updates and access to previous versions.

10. Work with a French translator specialising in medical devices

Medical device translation requires more than linguistic accuracy. A specialist translator understands medical terminology, device functionality, regulatory requirements and the importance of safety-critical information. This expertise helps ensure that French documentation is technically accurate, consistent across materials and appropriate for its intended users, reducing the risk of translation errors that could affect device safety or regulatory compliance. 



Contact Emi Lecret for specialist support with:




📩 Contact me

emi lecret

Emi Lecret – Medical writer | Translator | Localization specialist | Communication strategist for MedTech companies


Share

By Emi Lecret • September 16, 2026
Medical devices placed on the French market are primarily regulated under the EU medical device framework, supplemented by national French legislation and requirements.
clinician using a medical device user interface
By Emi Lecret • September 7, 2026
How inconsistent terminology between medical device IFUs and UIs can affect usability, patient safety, regulatory approval, and French localisation quality.
By Emi Lecret • August 25, 2026
Healthcare trade shows create a concentrated environment in which MedTech, HealthTech and digital health companies can demonstrate products, meet healthcare professionals, speak with hospital buyers, identify distributors, develop partnerships and generate new business opportunities. For international companies exhibiting in France or another French-speaking market, MedTech marketing content plays an important role throughout that journey. Visitors may encounter a company before the event through a campaign or exhibitor profile, discover its technology on the stand, scan a QR code during a demonstration and return to a landing page afterwards.  Effective MedTech trade show marketing therefore depends on creating a coherent sequence of interactions rather than a collection of isolated materials. The language, terminology, product story and calls to action should help the right visitors understand what the technology does, why it may be relevant to them and what they should do next.